| The master neural transcription factor BRN2 is an androgen receptor–suppressed driver of neuroendocrine differentiation in prostate cancer JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ... Cancer discovery 7 (1), 54-71, 2017 | 344 | 2017 |
| Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma KSS Enfield, EA Marshall, C Anderson, KW Ng, S Rahmati, Z Xu, M Fuller, ... Nature communications 10 (1), 5438, 2019 | 52 | 2019 |
| Combined AKT and MEK pathway blockade in pre-clinical models of enzalutamide-resistant prostate cancer P Toren, S Kim, F Johnson, A Zoubeidi PLoS One 11 (4), e0152861, 2016 | 37 | 2016 |
| SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria Y Xue, JL Morris, K Yang, Z Fu, X Zhu, F Johnson, B Meehan, L Witkowski, ... Nature Communications 12 (1), 5404, 2021 | 24 | 2021 |
| CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development ES Melese, E Franks, RA Cederberg, BT Harbourne, R Shi, ... Oncoimmunology 11 (1), 2010905, 2022 | 23 | 2022 |
| Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer Y Inoue, A Nikolic, D Farnsworth, R Shi, FD Johnson, A Liu, M Ladanyi, ... Elife 10, e66524, 2021 | 16 | 2021 |
| Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells FD Johnson, J Ferrarone, A Liu, C Brandstädter, R Munuganti, ... Cell reports 38 (6), 2022 | 14 | 2022 |
| MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression DA Farnsworth, Y Inoue, FD Johnson, G de Rappard-Yuswack, D Lu, ... NPJ Precision Oncology 6 (1), 88, 2022 | 12* | 2022 |
| Methionine-producing tumor micro (be) environment fuels growth of solid tumors AA Vega, EA Marshall, AJC Noonan, FSL Filho, J Yang, GL Stewart, ... Cellular Oncology 46 (6), 1659-1673, 2023 | 7 | 2023 |
| HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner B Turgu, F Zhang, A El-Naggar, GL Negri, M Kogler, L Tortola, F Johnson, ... Oncogene 40 (11), 1988-2001, 2021 | 5 | 2021 |
| Tandem mass tag-based thermal proteome profiling for the discovery of drug-protein interactions in cancer cells FD Johnson, CS Hughes, A Liu, WW Lockwood, GB Morin STAR protocols 4 (1), 102012, 2023 | 1 | 2023 |
| Characterizing the secretome of EGFR mutant lung adenocarcinoma JK Luu, FD Johnson, J Jajarmi, T Sihota, R Shi, D Lu, D Farnsworth, ... Frontiers in Oncology 13, 1286821, 2024 | | 2024 |
| Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells P Sathiyaseelan, S Chittaranjan, SE Kalloger, J Chan, NE Go, MA Jardon, ... Journal of Cell Science 136 (19), jcs260644, 2023 | | 2023 |
| EP08. 02-055 Targeting Lung Adenocarcinoma Cells with a Novel Disulfide Reductase Inhibitor F Johnson, J Ferrarone, A Liu, C Brandstädter, R Munuganti, ... Journal of Thoracic Oncology 17 (9), S424, 2022 | | 2022 |
| B13 Selectively Targeting Lung Cancer with a Novel Small Molecule that Induces Lethality Through Dual Inhibition of Disulfide Reductases FD Johnson, S Jansen, A Liu, C Brandstädter, D Lu, A Nagelberg, ... Journal of Thoracic Oncology 15 (2), S31-S32, 2020 | | 2020 |
| Abstract A033: Identity fraud: Lineage plasticity as a mechanism of antiandrogen resistance and target for therapy A Davies, C Bostock, M Ahmed, YY Lin, F Johnson, KM Nip, K Ketola, ... Cancer Research 78 (16_Supplement), A033-A033, 2018 | | 2018 |
| Identity fraud: Lineage plasticity as a mechanism of anti-androgen resistance and target for therapy AH Davies, C Bostock, M Ahmed, YY Lin, F Johnson, KM Nip, K Ketola, ... Cancer Research 78 (13_Supplement), 4995-4995, 2018 | | 2018 |
| EZH2 reprogramming confers intrinsic stem cell properties and developmental plasticity driving neuroendocrine prostate cancer A Davies, M Ahmed, C Bostock, A Gleave, K Ketola, F Johnson, J Bishop, ... Cancer Research 77 (13_Supplement), 5025-5025, 2017 | | 2017 |
| The Plasticity of Stem-Like States in Patient-Derived Tumor Xenografts AH Davies, F Johnson, K Ketola, A Zoubeidi Patient-Derived Xenograft Models of Human Cancer, 71-91, 2017 | | 2017 |
| Methionine-Producing Tumour Micro (Be) Environment Fuels Growth of Solid Tumours EA Marshall, AA Vega, AJC Noonan, S Leitao Filho, JSW Yang, ... | | |
